Aducanumab (Anti-Amyloid Beta)
Aducanumab (Anti-Amyloid Beta) is a selective human monoclonal antibody targeting aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.MW :145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2588 |
Sku # | A2588-1mg*5 |
Pricing | 1mg*5, $790.00 |